Skip to main content
. 2017 Mar 15;2017(3):CD012600. doi: 10.1002/14651858.CD012600

Wapner 2003.

Clinical features and settings Routine screening
Participants 8216 participants
USA multicentre study (12 prenatal diagnostic centres)
Dates not specified
Singleton pregnancies
Pregnant women
Mean age 35 years (SD 4.6), 50% ≥ 35 years
11 to 14 weeks' gestation
Study design Prospective cohort
Target condition and reference standard(s) Down's syndrome: 61 cases
Reference standards: invasive testing. Miscarriage with cytogenetic testing. Follow‐up to birth
Index and comparator tests Maternal age
First trimester NT (FMF methods)
Dried blood samples tested for:
First trimester free ßhCG and PAPP‐A (dried blood samples, enzyme‐linked immunoadsorbent assay as previously described)
Risk cut‐point 1:270
Follow‐up Follow‐up to birth by directly following up women and reviewing delivery records. An effort was also made to obtain information on terminated or miscarried pregnancies. 196 (2.3%) of patients without follow‐up information were excluded and women with a previous trisomy 18 or 21 pregnancy were also excluded
Aim of study To evaluate the use of combined first trimester markers for aneuploidy in clinical practice
Notes 16 live Down’s syndrome births
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population 
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Yes All women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements
Withdrawals explained? 
 All tests No No details of withdrawals given